NOCRF yields 1470.59% · MRK yields 2.81%● Live data
📍 NOCRF pulled ahead of the other in Year 1
Combined, NOCRF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NOCRF + MRK for your $10,000?
Norden Crown Metals Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Sweden and Norway. The company primarily explores for zinc, lead, copper, silver, and gold deposits. It holds 100% interests in the Gumsberg VMS project that consists of five exploration licenses, which covers an area of approximately 16,370 hectares located in the Bergslagen mining district of southern Sweden; and the Burfjord copper-gold project with seven exploration licenses covering an area of approximately 6,200 hectares located in Alta, Norway. The company was formerly known as Boreal Metals Corp. and changed its name to Norden Crown Metals Corp. in October 2020. Norden Crown Metals Corp. was incorporated in 2013 and is headquartered in North Vancouver, Canada.
Full NOCRF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.